by healthadvances Posted on June 24, 2022June 24, 2022 From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology Read More
by healthadvances Posted on June 16, 2022June 16, 2022 ASCO 2022: Striving to Ensure No Patient is Left Behind Read More
by healthadvances Posted on May 4, 2022 Digital Health in Japan and Korea – Where Is It Heading? Read More
by healthadvances Posted on May 2, 2022 Opportunities and Challenges for Drug Makers in MDD Read More
by healthadvances Posted on February 25, 2022 Strategies to Overcome Challenges in Commercializing Treatments for Rare Diseases Read More
by healthadvances Posted on February 15, 2022 Women’s Health at Home: Reflections on a Rapidly Growing Space Read More
by healthadvances Posted on October 8, 2021 Building and Defending Markets; Reflections on Attending DTx and NASS Conferences Read More
by healthadvances Posted on October 1, 2021October 1, 2021 Resurgence in Drug Development for Renal Diseases Read More
by healthadvances Posted on September 29, 2021October 1, 2021 AI in Healthcare: Insights from Two Decades of FDA Approvals Read More
by healthadvances Posted on August 6, 2021August 9, 2021 Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better? Read More
by healthadvances Posted on July 21, 2021 India, the Generic Manufacturing Powerhouse, Biosimilar Next? Read More
by healthadvances Posted on June 30, 2021 Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies? Read More
by healthadvances Posted on September 15, 2020 Hong Kong Exchange: Nurturing China’s Biotech Valley Read More
by healthadvances Posted on April 1, 2020April 13, 2020 Will Healthcare Ever Be the Same Again After COVID-19? Read More
by healthadvances Posted on February 28, 2020April 13, 2020 Overcoming Challenges to Realize the Promise of Genetic Medicine Read More
by healthadvances Posted on February 27, 2020April 13, 2020 Reflecting on the 17th Annual HBS Healthcare Conference Read More
by healthadvances Posted on July 23, 2019December 7, 2021 E-Health in Germany: Three New Laws Signify the Imminent Transformation to a Digitalised Healthcare System Read More
by healthadvances Posted on September 18, 2018April 13, 2020 New Assessment Pathway for Invasive High-Risk Medical Devices in Germany: Balancing Market Access, Evidence and Patient Benefit Read More